KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Operating Expenses: 2018-2024

Historic Other Operating Expenses for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $4.3 million.

  • Aurinia Pharmaceuticals' Other Operating Expenses rose 79.69% to -$929,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year decrease of 9.37%. This contributed to the annual value of $4.3 million for FY2024, which is 151.88% up from last year.
  • Aurinia Pharmaceuticals' Other Operating Expenses amounted to $4.3 million in FY2024, which was up 151.88% from -$8.4 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Other Operating Expenses ranged from a high of $4.3 million in FY2024 and a low of -$8.4 million during FY2023.
  • For the 3-year period, Aurinia Pharmaceuticals' Other Operating Expenses averaged around -$836,333, with its median value being $1.5 million (2022).
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Other Operating Expenses surged by 365.33% in 2022, and later plummeted by 650.16% in 2023.
  • Aurinia Pharmaceuticals' Other Operating Expenses (Yearly) stood at -$6.8 million in 2020, then skyrocketed by 91.57% to -$574,000 in 2021, then spiked by 365.33% to $1.5 million in 2022, then tumbled by 650.16% to -$8.4 million in 2023, then surged by 151.88% to $4.3 million in 2024.